Innovent Updates Phase 1b Data of IBI939 AntiTIGIT Monoclonal Antibody Combined with Sintilimab in Previously…
ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment…